We design ground-breaking therapies through precision-targeting of membrane receptors to bring hope to people living with autoimmune diseases

Innovative chemistry to design modulators of key membrane receptors

Development and discovery programs to treat autoimmune diseases

Multidisciplinary team in drug development and world-class key opinion leaders

Find Therapeutics is clinical-stage biopharmaceutical company dedicated to the development of next generation therapies to treat inflammatory autoimmune diseases. The company was launched in 2020 and is supported with investments from CTI Life Sciences, adMare BioInnovations, Domain Therapeutics and Investissment Québec and an exclusive license from SATT-Conectus and the University of Strasbourg on a technology and related know-how.